iBio (IBIO) Payables (2011 - 2026)

iBio (IBIO) has 16 years of Payables data on file, last reported at $3.0 million in Q1 2026.

• On a quarterly basis, Payables rose 57.09% year-over-year to $3.0 million in Q1 2026; TTM through Mar 2026 was $3.0 million, a 57.09% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 514.14% from the prior year.
• Payables for Q1 2026 stood at $3.0 million, up from $2.7 million in the prior quarter.
• Over the last five years, Payables for IBIO reached as high as $27.0 million in Q3 2022 and fell as low as $481000.0 in Q2 2024.
• Historically, Payables has averaged $9.9 million across 5 years, with a median of $5.3 million in 2022.
• Across the five-year window, Payables soared 1078.36% in 2022 and sank 96.75% in 2024, its largest moves.
• Year by year, Payables stood at $20.0 million in 2022, then dropped by 27.48% to $14.5 million in 2023, then slumped by 94.14% to $851000.0 in 2024, then jumped by 211.87% to $2.7 million in 2025, then climbed by 14.36% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $3.0 million in Q1 2026, $2.7 million in Q4 2025, and $3.5 million in Q3 2025.